Canada markets closed

Evolent Health, Inc. (EVH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
27.65-0.67 (-2.37%)
At close: 04:00PM EDT
27.65 0.00 (0.00%)
After hours: 04:53PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.15B
Enterprise Value 3.60B
Trailing P/E N/A
Forward P/E 19.96
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.57
Price/Book (mrq)2.95
Enterprise Value/Revenue 1.83
Enterprise Value/EBITDA -145.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 3-24.12%
S&P500 52-Week Change 322.36%
52 Week High 336.70
52 Week Low 323.33
50-Day Moving Average 331.74
200-Day Moving Average 329.37

Share Statistics

Avg Vol (3 month) 3919.79k
Avg Vol (10 day) 3835.4k
Shares Outstanding 5113.89M
Implied Shares Outstanding 6117.67M
Float 8109.04M
% Held by Insiders 14.17%
% Held by Institutions 1112.14%
Shares Short (Apr 15, 2024) 411.38M
Short Ratio (Apr 15, 2024) 415.08
Short % of Float (Apr 15, 2024) 411.72%
Short % of Shares Outstanding (Apr 15, 2024) 49.99%
Shares Short (prior month Mar 15, 2024) 410.81M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -5.76%
Operating Margin (ttm)1.23%

Management Effectiveness

Return on Assets (ttm)0.86%
Return on Equity (ttm)-10.74%

Income Statement

Revenue (ttm)1.96B
Revenue Per Share (ttm)17.65
Quarterly Revenue Growth (yoy)45.40%
Gross Profit (ttm)N/A
EBITDA 127.5M
Net Income Avi to Common (ttm)-142.26M
Diluted EPS (ttm)-1.28
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)192.82M
Total Cash Per Share (mrq)1.69
Total Debt (mrq)644.8M
Total Debt/Equity (mrq)51.74%
Current Ratio (mrq)1.01
Book Value Per Share (mrq)9.38

Cash Flow Statement

Operating Cash Flow (ttm)142.58M
Levered Free Cash Flow (ttm)172.48M